Why don't COVID-19 vaccines last longer? | World Economic Forum
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil | Nature Communications
Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine | FDA
Durability of Bivalent Boosters against Omicron Subvariants | NEJM
Chart Shows How Fast COVID Booster Shot Protection Kicks in
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel | NEJM
COVID-19 vaccine surveillance report: week 44
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet
Effectiveness of COVID-19 booster vaccination strategies in partially vaccinated populations
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years — United States, August 13, 2021–November 19, 2021 | MMWR
Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA
What We Know So Far About Waning Vaccine Effectiveness - The New York Times
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina | NEJM
Booster needed to neutralize the fast-spreading variant | World Economic Forum
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England | Nature Medicine
Protection duration after vaccination or infection, and efficacy of a third dose by vaccination or booster by infection – Swiss National COVID-19 Science Task Force
COVID-19 Vaccine Boosters at VA Long Beach and New Website
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study - The Lancet
COVID-19 vaccine breakthrough infections | Science
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design - The Lancet Infectious Diseases
Boosting immunity to COVID-19 vaccines | Nature Medicine
